As the headquarters of AGC Biologics, the Seattle site is a cornerstone of the company’s global network, renowned for its technical expertise and collaborative spirit. Michael Brotz, Director of Manufacturing Science and Technology (MSAT), bridges the complex worlds of technical production, client relations, and manufacturing innovation to help our pharmaceutical developers bring life-changing therapeutics to market.
The Seattle campus is AGC Biologics' global headquarters and Center of Excellence for global formulation services. It features cutting-edge capabilities, including multiple cGMP manufacturing lines and scalable mammalian and microbial biologics production. The team employs advanced fed-batch and perfusion manufacturing processes and offers both stainless steel and single-use bioreactor systems to meet a wide variety of client needs.
“Our flexibility is what sets us apart,” Brotz explains. “From monoclonal antibodies to fusion and recombinant proteins, we can develop any type of protein needed. Our ability to start projects in Seattle and seamlessly transfer them to our other global sites ensures efficiency and adaptability for clients.”
A Collaborative Life Sciences Community
Beyond its technical capabilities, the Seattle campus thrives within the unique life sciences ecosystem. According to Brotz, the tight-knit biotech community fosters shared innovation and talent development, advancing the industry as a whole.
“Our region stands out because of this cooperative spirit,” says Brotz. “It’s rare to see this level of collaboration in a major metropolitan area.”
With over 30 years of operational experience and a passionate, skilled team, the AGC Biologics Seattle campus exemplifies the innovation and dedication that drives success in the CDMO space.
Interested in learning how AGC Biologics can support your project? Explore opportunities and services at our Seattle site today.
